Background
==========

This case represents a rare variant of catecholamine-producing tumor with distinct histological features. A potential relationship between the phenotype, the cellular origin and the genetic alterations is discussed.

Case presentation
=================

A 77-year-old patient with a history of arterial hypertension, intermittent atrial fibrillation and an episode of Takot-tsubo-cardiomyopathy presented for pre-surgical evaluation of suspected catecholamine excess.

Investigation
=============

Repeated laboratory examinations documented elevated plasma and urine metanephrine (urine metanephrine 6205.88 μg/24 h (\<699.66 μg/24 h), normethanephrine 4013.1 μg/24 h (\<1698.06 μg/24 h) and plasma metanephrine 1460.16 pmol/l (\<465.3 pmol/l), normetanephrine 1116.72 pmol/l (\<982.8 pmol/l)). A combined ^18^F-DOPA-PET/CT scan revealed presence of a clearly DOPA-positive (SUVmax 7,8) lesion considered to be arising from the left adrenal gland, measuring 3.0×3.3 cm ([Fig. 1](#fig1){ref-type="fig"}).

![Combined DOPA-PET/CT scan of the abdomen showing an intensively DOPA-positive lesion on the upper left kidney pole.](edmcr-2016-150117-g001){#fig1}

Pathologic findings
-------------------

The resected tumor measured 3.5×3.2×2.2 cm and weighed 37g including adjacent adrenal tissue. The tumor was relatively well demarcated with macroscopically red to black color, surrounded by a thin golden-yellow rim representing the preexistent adrenal cortex. Histological slides showed compact groups of cells, partly with huge bizarre, hyperchromatic cell nuclei, and pigment inclusions within the granular cytoplasm. Because of the macroscopical appearance there was initial suspicion of malignant melanoma but in consideration of the clinically and radiologically clear indication of pheochromocytoma, additional immunohistochemical analyses were performed. Tumor cells showed an intense expression of chromogranin A and synaptophysin, S100 was positive only in sustentacular cells ([Fig. 2](#fig2){ref-type="fig"}A, B, C and D). HMB45, a marker of melanosomes showed focal positive cytoplasmic staining ([Fig. 2](#fig2){ref-type="fig"}F) and Melan A was negative ([Fig. 2](#fig2){ref-type="fig"}E). These features led to the final diagnosis of a melanotic pheochromocytoma ([Fig. 3](#fig3){ref-type="fig"}).

![The hematoxylin eosin staining (A) shows highly vascularized tumor tissue, composed of highly pleomorphic, basophilic tumor cells. The positive staining of chromogranin A (B) and synaptophysin (C) of the tumor cells and the presence of S100 positive cells (D) surrounding the tumor cells, confirms this tumor is a pheochromocytoma. Melan-A staining is negative in the tumor cells (E), while the remaining cortex stains positive. HMB45, a marker for melanosomes, shows focal positive cytoplasmic staining (F).](edmcr-2016-150117-g002){#fig2}

![Macroscopic aspect of the resected tumor (following paraffin embedding).](edmcr-2016-150117-g003){#fig3}

Targeted next generation sequencing including *EPAS1, FH, HRAS, KIF1B, MAX, MDH2, MEN1, NF1, RET, SDHA, SDHAF1, SDHAF2, SDHB, SDHC, SDHD, TMEM127* and *VHL* was done on the tumor DNA, which revealed a somatic *RET* mutation in exon 16 (*RET* c.2753T\>C, p.Met918Thy), further validated by Sanger sequencing. An underlying MEN2 syndrome was excluded by sequencing the germline DNA.

Treatment
=========

The patient was treated preoperatively with alpha blockade and underwent uneventful left-sided laparoscopic adrenalectomy. After a short recovery period the patient was discharged from the hospital without need for antihypertensive medication.

Outcome and follow-up
=====================

Follow-up examinations 3 and 6 month after surgery revealed normalization of plasma catecholamines. Following current guideline suggestions yearly follow-up examinations were recommended ([@bib1]).

The patient was enrolled into the registry and biobank of the European Network for the Study of Adrenal Tumors ([www.ensat.org](http:\\www.ensat.org)) upon written informed consent.

Discussion
==========

Similar to other reports in the literature the black pigmentation of the tumor first led to the suspicion of a metastasis deriving from a malignant melanoma. In fact, black pheochromocytomas (PCC) are very rarely found. In a well defined sub-cohort of 766 PCC/paraganglioma (PGL) patients registered in the ENSAT registry (from Munich, Rotterdam, Madrid, Dresden and Paris) this is the first reported case of a 'black' pheochromocytoma. In the literature, only 18 cases of pigmented PGL and one macro-and 11 microscopically pigmented pheochromocytomas have been reported ([Table 1](#tbl1){ref-type="table"}), which emphasizes the rareness of this finding. However, several cases of pigmented tumors, ([@bib2]), ([@bib3]) among which neuroblastomas, schwannomas or adrenocortical adenoma, had been described in the past. Ikeda *et al*. ([@bib4]) reported a case of an medullary thyroid carcinoma (MTC) with a PGL-like pattern and melatonin production. The tumor showed the PGL-typical 'sustentacular cells' as well as pigmented dendritic cells. Genetic analysis unfortunately is not available in this case.

###### 

Previous case reports of pigmented pheochromocytoma and pigmented paraganglioma

  **Reference**                     **Case No.**   **Macroscopic pigment**   **Microscopic pigment**   **Location**                                                **Mutation**
  --------------------------------- -------------- ------------------------- ------------------------- ----------------------------------------------------------- --------------
  Pigmented pheochromocytoma                                                                                                                                       
   Landas *et al*. ([@bib7])        6                                        6                                                                                     
   Chetty *et al*. ([@bib8])        3                                        3                                                                                     
   Langer *et al*. ([@bib9])        1                                        1                                                                                     
   Bellezza *et al*. ([@bib10])     1              1                                                                                                               
   Handa *et al*. ([@bib11])        1                                        1                                                                                     
   Present case                     1              1                                                                                                               
  Pigmented paraganglioma                                                                                                                                          
   Stout (1935)                     1                                                                  Ganglion nodosum                                            NR
   Tavassoli ([@bib12])             2                                                                  Uterus                                                      NR
   Paulus *et al*. ([@bib13])       1                                                                  Orbit                                                       NR
   Hofmann *et al*. ([@bib14])      1                                                                  Posterior mediastinum                                       NR
   Küchemann ([@bib15])             1                                                                  Retroperitoneum                                             NR
   Moran *et al*. ([@bib16])        5                                                                  Bladder, spine (2), anterior mediastinum, retroperitoneum   NR
   Lack *et al*. ([@bib5])          1                                                                  Retroperitoneum                                             NR
   Mikolaenko *et al*. ([@bib17])   1                                                                  Heart                                                       NR
   Dundr *et al*. ([@bib18])        1                                                                  Urinary bladder                                             NR
   Reddy *et al*. ([@bib19])        1                                                                  Vagal trunk                                                 NR
   Miraldi *et al*. ([@bib20])      1                                                                  Heart                                                       NR
   Gonnella *et al*. ([@bib21])     1                                                                  Heart                                                       NR
   Petramala *et al*. ([@bib22])    1                                                                  Heart                                                       *SDHB*
   Zhao *et al*. ([@bib23])         1                                                                  Kidney                                                      NR

NR, not reported.

Reported histopathological results regarding the pigment differed, but in most cases lipofuscin, true melanin and neuromelanin were found ([@bib5]). In our case, the positive HMB45 staining indicates that the pigment results from the presence of melanosomes in at least some of the tumor cells. While true melanin is a pigment produced by melanocytes from [l]{.smallcaps}-DOPA, neuromelanin and lipofuscin are byproducts of the macro-autophagy pathway and are associated with breakdown of mitochondria (lipofuscin) and metabolism of catecholamines (neuromelanin) ([@bib5]). Neuromelanin can also be found in neurons of the substantia nigra. Sulzer *et al*. ([@bib6]) have shown that [l]{.smallcaps}-DOPA induced elevation of cytosolic dopamine is responsible for extended neuromelanin biosynthesis. Thus, neuromelanin and lipofuscin are probably related to excessive catecholamine oxidation. It is suggestive that the tumor cells in pheochromocytoma would contain neuromelanin rather than melanin, also because they possess the enzymes ([l]{.smallcaps}-DOPA) to produce it. However, a clear distinction between melanin and neuromelanin cannot be drawn by immunohistochemical staining procedures alone.

The somatic *RET* mutation found in our case is of interest as also non-catecholamine producing but MEN2 associated tumors such as MTC have been reported to occur as hyperpigmented. The rareness of this association clearly indicates that *RET* mutations are not sufficient to cause a hyperpigmentation phenotype. However, it is of interest, that melanocytes, C-cells and adrenal medullary cells share common embryogenetic origins from the neural crest. This common ancestry could be the basis for shared morphological features during tumor development. However, as pigmentation is not an usual feature in non-melanotic tumors, other molecular factors seem to be necessary to induce this particular phenotype.

Summary
-------

A 'black,', hyperpigmented, adrenal pheochromocytoma is a very rare variant of a catecholamine producing tumor which in the presented case was associated with the presence of melanosomes in tumor cells and the presence of somatic *RET* mutation. As pigmentation has also been described in non-catecholamine-producing tumor cells originating from the neural crest, such as MTC, common mechanisms for pigmentation in these tumor entities could be considered.
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